Home › Siemens Healthineers to Invest $300M to Expand Dx Manufacturing, R&D in Massachusetts

Siemens Healthineers to Invest $300M to Expand Dx Manufacturing, R&D in Massachusetts

Dec 14, 2016

NEW YORK (GenomeWeb) – Siemens Healthineers said today that it will invest $300 million to expand and upgrade its 500,000-sq. ft. laboratory diagnostics manufacturing and R&D facility in Walpole, Massachusetts, over the next four years.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jul
19
Featured Webinar

Advances in NGS for Ultra-High Sensitivity Applications in Translational and Clinical Research

Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research. 

Jul
25
Featured Webinar

Antibiotic Gene Surveillance: What You Don’t See Can Hurt You!

Sponsored by
Streck

This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms. 

What's Popular?

In Infectious Disease

  1. BARDA Awards up to $30M to Cue Health for Influenza, Respiratory Pathogen Test Development

  2. Cue Health Closes $45M Series B Financing

  3. Ceres' Lyme Test Receives Breakthrough Device Designation from FDA

  4. FDA Clears Roche's PCT Assay for Expanded Use

  5. Sight Diagnostics Launches POC System for Complete Blood Count in Europe With Plans for US Market

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.